- Q1 2024 Emergent BioSolutions Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Emergent BioSolutions Inc Earnings Call TranscriptMar 06, 2024€3.04 (-3.55%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Emergent BioSolutions Inc Earnings Call TranscriptNov 08, 2023€2.22 (+2.58%)Earnings
- Q2 2023 Emergent BioSolutions Inc Earnings Call TranscriptAug 08, 2023€6.66 (+0.60%)Earnings
- Q1 2023 Emergent BioSolutions Inc Earnings Call TranscriptMay 09, 2023€8.26 (+2.48%)Earnings
- Q4 2022 Emergent BioSolutions Inc Earnings Call TranscriptFeb 27, 2023€12.94 (-3.53%)Earnings
- Q3 2022 Emergent BioSolutions Inc Earnings Call TranscriptNov 08, 2022€20.18 (+0.96%)Earnings
- Q2 2022 Emergent BioSolutions Inc Earnings Call TranscriptAug 01, 2022€33.67 (-4.70%)Earnings
- Emergent BioSolutions Inc at Goldman Sachs Leveraged Finance and Credit Conference TranscriptMay 12, 2022
- Emergent BioSolutions Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Emergent BioSolutions Inc Earnings Call TranscriptApr 28, 2022€34.68 (-0.43%)Earnings
- Emergent BioSolutions Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) TranscriptMar 22, 2022
- Q4 2021 Emergent BioSolutions Inc Earnings Call TranscriptFeb 24, 2022€36.49 (-3.85%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Emergent BioSolutions Inc Earnings Call TranscriptNov 04, 2021€45.25 (+3.38%)Earnings
- Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Emergent BioSolutions Inc Earnings Call TranscriptJul 29, 2021€54.82 (+4.30%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 20, 2021
- Q1 2021 Emergent BioSolutions Inc Earnings Call TranscriptApr 29, 2021€50.48 (-4.07%)Earnings
- Emergent BioSolutions Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Emergent BioSolutions Inc Earnings Call TranscriptFeb 18, 2021€101Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Q3 2020 Emergent BioSolutions Inc Earnings Call TranscriptNov 05, 2020€84 (+5.66%)Earnings
- Emergent BioSolutions Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Emergent BioSolutions Inc Earnings Call TranscriptJul 30, 2020€80 (+2.56%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Emergent BioSolutions Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Emergent BioSolutions Inc Earnings Call TranscriptApr 30, 2020€68.5 (+0.74%)Earnings
- Q4 2019 Emergent BioSolutions Inc Earnings Call TranscriptFeb 20, 2020€59.5 (+0.85%)Earnings
- Emergent BioSolutions Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Emergent BioSolutions Inc Analyst and Investor Day TranscriptNov 21, 2019
- Q3 2019 Emergent BioSolutions Inc Earnings Call TranscriptNov 06, 2019€52 (+2.97%)Earnings
- Q2 2019 Emergent BioSolutions Inc Earnings Call TranscriptAug 01, 2019€39.65 (-0.92%)Earnings
- Emergent BioSolutions Inc Annual Shareholders Meeting TranscriptMay 23, 2019
- Q1 2019 Emergent BioSolutions Inc Earnings Call TranscriptMay 02, 2019€46.51 (-2.15%)Earnings
- Q4 2018 Emergent BioSolutions Inc Earnings Call TranscriptFeb 21, 2019€57.45 (-0.95%)Earnings
Emergent BioSolutions Inc at Bank of America Healthcare Conference Transcript
(technical difficulty) Bob Burrows, Vice President of Investor Relations; and Rich Lindahl, our Chief Financial Officer.
For those of you that don't know, Emergent BioSolutions is a kind of a global biopharmaceutical company that is specialized in kind of public health threats and combating public health threats. And with that, I'll go ahead and turn over to Rich, I don't know if you want to do an introduction or just kind of an overview and maybe talk about some of the recent events, and then we get into more of the dialogue here.
Sure. So thank you very much for having us. I appreciate it. Yes, as Larry said, we're a company that focuses on providing solutions to public health reps, whether they be kind of naturally, accidentally or deliberately occurring.
To that end, we have a suite of products and services, which we'll talk about in more detail as we go through the conversation centered around vaccines, therapeutics and drug-device
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)